Elevance Health (ELV) EPS (Basic) (2009 - 2026)

Elevance Health (ELV) has 17 years of EPS (Basic) data on file, last reported at $6.7 in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 13.48% year-over-year to $6.7 in Q2 2026; TTM through Jun 2026 was $22.8, a 4.02% decrease from a year earlier, with the FY2025 full-year figure at $25.27, down 1.93% from the prior year.
• EPS (Basic) for Q2 2026 stood at $6.7, down from $8.01 in the prior quarter.
• Over the last five years, EPS (Basic) for ELV reached as high as $9.91 in Q2 2024 and fell as low as $1.78 in Q4 2024.
• Historically, EPS (Basic) has averaged $6.41 across 5 years, with a median of $6.74 in 2022.
• Across the five-year window, EPS (Basic) sank 49.4% in 2024 and soared 36.75% in 2025, its largest moves.
• Year by year, EPS (Basic) stood at $3.65 in 2022, then decreased by 3.6% to $3.52 in 2023, then sank by 49.4% to $1.78 in 2024, then soared by 36.75% to $2.44 in 2025, then soared by 174.89% to $6.7 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $6.7 in Q2 2026, $8.01 in Q1 2026, and $2.44 in Q4 2025.